Devices › Device types
FDA product code JJX · class 1 · Clinical Chemistry
Single (specified) analyte controls (assayed and unassayed): medical device reports filed with FDA
672 reports carry this product code, 1994–2026; 8 brands with a page.
- 672
- reports with this product code
- 0% of all MAUDE reports
- 20
- reports, 12 months to August 2026
- 20 in the 12 months before
- 92.9%
- classified as malfunction
- 62.3% across all reports
- 0%
- classified as death, as reported
- 0.9% across all reports
Product code JJX is FDA's classification for "Single (specified) analyte controls (assayed and unassayed)" (clinical Chemistry panel), a class 1 device. 672 medical device reports carry this product code, 0% of the MAUDE database, from February 1994 to July 2026.
20 reports arrived in the 12 months to August 2026, close to the 20 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (92.9%), injury (5.4%) and other (1%). 8 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Contour Next | 445 | 33 | 0% | 82.4% |
| Contour | 40 | 38 | 0% | 85.3% |
| True Metrix | 8 | 273 | 0.4% | 65.3% |
| Contour Ts | 2 | 0 | 0% | 85.1% |
| ARCHITECT Syphilis TP | 1 | 22 | 0% | 90.2% |
| Breeze2 | 1 | 0 | 0% | 76.2% |
| Nova Max Plus Glucose Monitor | 1 | 0 | 0% | 72.8% |
| Truetrack | 1 | 0 | 0% | 98.4% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Ascensia Diabetes Care US | 453 | 67.4% |
| Bayer Healthcare | 48 | 7.1% |
| Haemonetics | 35 | 5.2% |
| Mhc Medical Products | 12 | 1.8% |
| Trividia Health | 9 | 1.3% |
| Roche Diabetes Care | 5 | 0.7% |
| Nipro Diagnostics | 4 | 0.6% |
| Nova Biomedical | 4 | 0.6% |
| Abbott Point Of Care | 2 | 0.3% |
| Lifescan Europe | 2 | 0.3% |
| Abbott Germany | 1 | 0.1% |
| Lifescan | 1 | 0.1% |
| Tosoh Hi-Tec | 1 | 0.1% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Incorrect, inadequate or imprecise result or readings | 335 | 49.9% |
| High test results | 67 | 10% |
| Device operates differently than expectedthe device behaved unexpectedly | 66 | 9.8% |
| Incorrect or inadequate test results | 48 | 7.1% |
| Display or visual feedback problem | 46 | 6.8% |
| Improper or incorrect procedure or method | 20 | 3% |
| Fluid/blood leak | 15 | 2.2% |
| Breakthe device broke | 10 | 1.5% |
| Leak/splashthe device leaked | 9 | 1.3% |
| Low test results | 9 | 1.3% |
| Material frayed | 8 | 1.2% |
| Nonstandard device | 8 | 1.2% |
| Use of incorrect control/treatment settings | 8 | 1.2% |
| Missing information | 7 | 1% |
| Smoking | 7 | 1% |
| High readingsreadings were too high | 6 | 0.9% |
| Output problem | 6 | 0.9% |
| Calibration problem | 5 | 0.7% |
| Device operational issue | 5 | 0.7% |
| Cut in material | 4 | 0.6% |
Questions about single (specified) analyte controls (assayed and unassayed) reports
What is product code JJX?
FDA's classification code for "Single (specified) analyte controls (assayed and unassayed)", class 1, reviewed by the clinical Chemistry panel. Every device report carries the product code of the device involved.
How many reports carry this code?
672 reports through August 2026, 20 of them in the latest 12 months.
Which brands appear most often?
Contour Next (445), Contour (40), True Metrix (8), Contour Ts (2) and ARCHITECT Syphilis TP (1). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.